INVO BIOSCIENCE INC (INVO)
US44984F4019 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 232.42K | 90.00K | 5.68M | 10.10M | 1.24M | |||
| Receivables | 140.55K | 80.00K | 50.00K | 20.00K | 10.00K | |||
| Inventories | 264.51K | 260.00K | 290.00K | 270.00K | 100.00K | |||
| Other Current Assets | 622.29K | 190.00K | 280.00K | 160.00K | 200.00K | |||
| Total Current Assets | 1.26M | 620.00K | 6.31M | 10.54M | 1.54M | |||
| Non-Current Assets | ||||||||
| PPE Net | 6.57M | 2.24M | 2.54M | 210.00K | 190.00K | |||
| Investments And Advances | 3.09M | 1.24M | 1.49M | 100.00K | N/A | |||
| Goodwill | 5.88M | N/A | N/A | N/A | N/A | |||
| Intangibles | 4.09M | 0.00 | 130.00K | 90.00K | 60.00K | |||
| Other Non-Current Assets | N/A | N/A | 0.00 | 0.00 | N/A | |||
| Total Non-Current Assets | 19.63M | 3.48M | 4.16M | 410.00K | 260.00K | |||
| TOTAL ASSETS | 20.89M | 4.10M | 10.47M | 10.95M | 1.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 880.00K | 660.00K | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 629.92K | 100.00K | 0.00 | 690.00K | 0.00 | |||
| Accrued Expenses | 1.12M | 1.18M | 800.00K | 550.00K | 410.00K | |||
| Accounts Payable | 2.33M | 1.35M | 440.00K | 330.00K | 370.00K | |||
| Other Current Liabilities | 3.26M | 120.00K | 10.00K | 720.00K | 720.00K | |||
| Total Current Liabilities | 8.22M | 3.41M | 1.25M | 2.29M | 1.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.25M | 0.00 | 0.00 | 0.00 | 350.00K | |||
| Deferred Taxes/Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 10.52M | 1.67M | 1.90M | 2.92M | 3.65M | |||
| Total Non-Current Liabilities | 11.78M | 1.67M | 1.91M | 2.91M | 4.01M | |||
| TOTAL LIABILITIES | 19.99M | 5.08M | 3.16M | 5.20M | 5.51M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -57.82M | -49.78M | -38.89M | -32.24M | -23.89M | |||
| Additional Paid In Capital | 52.71M | 48.80M | 46.20M | 37.98M | 20.16M | |||
| Common Shares | 6.00M | 0.00 | 0.00 | 0.00 | 20.00K | |||
| Shares Outstanding | 2.49M | 610.00K | 600.00K | 480.00K | 240.00K | |||
| Tangible Book Value per Share | -6.05 | -1.61 | 11.97 | 11.77 | -15.71 | |||
| Total Shareholders' Equity | 892.83K | -980.00K | 7.31M | 5.74M | -3.71M | |||
| TOTAL LIABILITIES AND EQUITY | 20.89M | 4.10M | 10.47M | 10.95M | 1.80M | |||
| Statistics | ||||||||
| Debt/Equity | 2.39 | N/A | N/A | N/A | -0.09 | |||
| Current Ratio | 0.15 | 0.18 | 5.05 | 4.60 | 1.03 | |||
| Return On Assets (ROA) | -38.47% | -265.61% | -63.51% | -76.26% | -120.56% | |||
| Return On Equity (ROE) | -899.90% | N/A | -90.97% | -145.47% | N/A | |||
All data in USD